… The COMPASS (Cardiovascular Outcomes for People Using Anticoagulation Strategies) …
-dose rivaroxaban and aspirin reduced major vascular events in patients with stable vascular …

… Rivaroxaban 2.5 mg twice daily plus acetylsalicylic acid (aspirin; ASA) 100 mg reduced the
risk of cardiovascular … in the COMPASS trial (Cardiovascular Outcomes for People Using …

… combination of low-dose rivaroxaban (2.5 mg twice daily) and aspirin (100 mg once daily) …
low-dose rivaroxaban (2.5 mg twice daily) to attenuate thrombin generation and aspirin (100 …

… cardiovascular events, especially in individuals with type 2 diabetes and proven cardiovascular
… rivaroxaban could influence endothelial function, arterial stiffness and platelet activation. …

… disease have demonstrated that a large proportion of vascular occlusions are mediated by …
of low-dose rivaroxaban with and without aspirin in stable coronary artery disease (CAD) and …

… rivaroxaban 5 mg twice-daily alone, the combination of rivaroxaban 2.5 mg twice-daily
and aspirin … Based on these results, the addition of rivaroxaban to aspirin is expected to …

… efficacy of reduced dose anticoagulation (rivaroxaban) in combination with aspirin in the …
(22), versus ASA alone in patients who are in sinus rhythm but at increased vascular risk. As …

… rivaroxaban alone or in combination with aspirin would be more effective than aspirin alone
for secondary cardiovascular … stable atherosclerotic vascular disease to receive rivaroxaban (…

… of low-dose rivaroxaban twice daily plus aspirin in stable PAD … low-dose rivaroxaban and
aspirin compared to aspirin alone … low-dose rivaroxaban plus aspirin compared to aspirin alone …

… once daily doses of rivaroxaban (20 and 10 mg) with aspirin (… whether both doses of
rivaroxaban are superior to aspirin for … comparing two doses of rivaroxaban with aspirin (clinicaltrials…